[go: up one dir, main page]

WO2017216162A1 - Composition d'hygiène personnelle - Google Patents

Composition d'hygiène personnelle Download PDF

Info

Publication number
WO2017216162A1
WO2017216162A1 PCT/EP2017/064419 EP2017064419W WO2017216162A1 WO 2017216162 A1 WO2017216162 A1 WO 2017216162A1 EP 2017064419 W EP2017064419 W EP 2017064419W WO 2017216162 A1 WO2017216162 A1 WO 2017216162A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
general formula
total weight
weight based
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2017/064419
Other languages
English (en)
Inventor
Nicholas John Ainger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Conopco Inc
Original Assignee
Unilever NV
Conopco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV, Conopco Inc filed Critical Unilever NV
Publication of WO2017216162A1 publication Critical patent/WO2017216162A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Definitions

  • the present invention relates to personal cleansing compositions such as liquid soaps, body washes and shampoos.
  • Personal cleansing compositions such as liquid soaps, body washes and shampoos are invariably based on surfactants.
  • Anionic surfactants such as sodium lauryl ether sulfate exhibit superior cleansing and foaming properties, and the established combination of sodium lauryl ether sulfate with cocamidopropylbetaine is still the most commonly used in such compositions.
  • Some consumers particularly those with dry and/or damaged hair, desire milder compositions.
  • One approach for providing mildness is to replace some of the sodium lauryl ether sulfate with co-surfactants.
  • Acyl glutamates have been identified as a class of co-surfactant which are particularly suitable for the production of shampoos for dry and/or damaged hair because of their mild, gentle cleansing action and affinity for keratin. Acyl glutamates have also been claimed to improve the dermatological characteristics of surfactant formulations containing sodium lauryl ether sulfate.
  • acyl glutamates are desirable co-surfactants in personal cleansing compositions for the reasons described above, they can be difficult to solubilize under some circumstances, leading to stringy or lumpy compositions. This is especially the case at low temperatures (e.g. 15°C or below). This represents a problem for the formulator, since such compositions are potentially unusable in countries where low temperatures prevail for all or part of the year.
  • the present invention provides a personal cleansing composition comprising, in an aqueous continuous phase:
  • a first anionic surfactant which is preferably selected from alkyl ether sulfates of general formula (I):
  • COR 1 is a linear or branched acyl group having 6 to 22 carbon atoms and 0,1 ,2 or 3 double bonds, and each X is independently hydrogen or a solubilising cation selected from alkali metal, ammonium, substituted ammonium or organic amine cations;
  • R 2 CO is a linear or branched acyl group having 6 to 22 carbon atoms and 0,1 ,2 or 3 double bonds; and R 1 is selected from Ci-4 alkyl groups and hydroxy-substituted C1-4 alkyl groups.
  • aqueous continuous phase is meant a continuous phase which has water as its basis.
  • the composition of the invention will comprise from about 50 to about 90%, preferably from about 55 to about 85%, more preferably from about 60 to about 85%, most preferably from about 65 to about 83% water (by weight based on the total weight of the composition).
  • composition of the invention comprises a first anionic surfactant which is preferably selected from alkyl ether sulfates of general formula (I) as defined above.
  • M is preferably sodium, potassium, ammonium or an alkanolamine (such as triethanolamine)
  • R is preferably a Cio or C12 linear alkyl group and the average degree of ethoxylation n preferably ranges from 2 to 4, more preferably from 2 to 3.5, most preferably from 2 to 3 and ideally from 2.2 to 3.
  • alkyl ether sulfate having general formula (I) for use in the invention is SLES 3EO (i.e. sodium lauryl ether sulfate in which the average degree of ethoxylation n is 3).
  • SLES 3EO i.e. sodium lauryl ether sulfate in which the average degree of ethoxylation n is 3
  • Commercially produced alkyl ether sulfates generally contain a mixture of homologues and the degree of ethoxylation is a statistical average value which may be an integer or a fraction.
  • the value of n in general formula (I) is governed by the starting molar ratio of ethylene oxide to aliphatic alcohol in the ethoxylation reaction and the temperature, time and catalytic conditions under which the ethoxylation reaction takes place.
  • a commercially produced alkyl ether sulfate having general formula (I) will usually comprise a mixture of homologues in which from 55 to 80 mol% of the total mixture is made up of homologues with ethoxy chains of 5EO or less (down to 0EO, i.e.
  • the level of first anionic surfactant (preferably alkyl ether sulfate of general formula (I)) will generally range from 3 to 12%, and preferably ranges from 4 to 10% by weight based on the total weight of the composition.
  • the first anionic surfactant is SLES 3EO (i.e. sodium lauryl ether sulfate in which the average degree of ethoxylation n is 3), in an amount ranging from 4 to 10% by weight based on the total weight of the SLES 3EO (i.e. sodium lauryl ether sulfate in which the average degree of ethoxylation n is 3), in an amount ranging from 4 to 10% by weight based on the total weight of the SLES 3EO (i.e. sodium lauryl ether sulfate in which the average degree of ethoxylation n is 3), in an amount ranging from 4 to 10% by weight based on the total weight of the SLES 3EO (i.e. sodium lauryl ether sulfate in which the average degree of ethoxylation n is 3), in an amount ranging from 4 to 10% by weight based on the total weight of the SLES 3EO (i.e. sodium lauryl ether sulfate in which the average degree of
  • composition of the invention comprises a second anionic surfactant which is different to the first anionic surfactant and which is selected from acyl glutamates of general formula (II) as defined above.
  • COR 1 in general formula (II) is selected from linear acyl groups having from 8 to 18 carbon atoms and 0, 1 , 2 or 3 double bonds and mixtures thereof.
  • X in general formula (II) is sodium, potassium, ammonium or an alkanolamine (such as triethanolamine).
  • COR 1 in general formula (II) is selected from lauroyi, myristoyi, palmitoyi, stearoyl, oleoyl and cocoyl groups and mixtures thereof. Most preferably COR 1 in general formula (II) is a cocoyl group.
  • the term "cocoyl” denotes a mixture of acyl groups having a distribution of carbon chain lengths
  • the carbon chain length distribution is generally defined follows: c 8 5 to 10 wt.%
  • acyl glutamates having general formula (I I) and suitable for use in the invention include sodium cocoyi glutamate (AMISOFT® CS-1 1 ex Ajinomoto Co. Inc.), disodium cocoyi glutamate (AMISOFT® ECS-22SB ex Ajinomoto Co. Inc.), triethanolammonium cocoyi glutamate (AMISOFT® CT-12 ex Ajinomoto Co. Inc.) triethanolammonium lauroyi glutamate (AMISOFT® LT-12 ex Ajinomoto Co. Inc.), sodium myristoyl glutamate (AMISOFT® MS-1 1 ex Ajinomoto Co. Inc.) , sodium stearoyl glutamate (AMISOFT® HS-1 1 P ex Ajinomoto Co. Inc.) and mixtures thereof.
  • AMISOFT® CS-1 1 ex Ajinomoto Co. Inc. sodium cocoyi glutamate
  • disodium cocoyi glutamate AMISOFT® ECS
  • Preferred acyl glutamates of general formula (II) for use in the invention include sodium cocoyi glutamate, disodium cocoyi glutamate and mixtures thereof.
  • the level of acyl glutamate of general formula (II) will generally range from 1 to 10%, and preferably ranges from 2 to 8% by weight based on the total weight of the composition.
  • the acyl glutamate of general formula (II) is selected from sodium cocoyi glutamate, disodium cocoyi glutamate and mixtures thereof, in an amount ranging from 2 to 8% by weight based on the total weight of the composition.
  • the composition of the invention comprises a nonionic surfactant selected from polyhydroxy fatty acid amides of general formula (III) as defined above.
  • R 2 CO is a linear or branched acyl group having 6 to 22 carbon atoms and 0,1 ,2 or 3 double bonds; and R 1 is selected from Ci-4 alkyl groups and hydroxy-substituted C1-4 alkyl groups.
  • R 2 CO in general formula (III) is selected from linear acyl groups having from 8 to 18 carbon atoms and 0, 1 , 2 or 3 double bonds and mixtures thereof.
  • R 2 CO in general formula (III) is selected from lauroyl, myristoyl, and cocoyl groups and mixtures thereof.
  • R 1 in general formula (III) is methyl.
  • Examples of commercially produced polyhydroxy fatty acid amides having general formula (III) and suitable for use in the invention include capryloyl/caproyl methyl glucamide (GlucoTain® Clear, ex Clariant Ltd.), lauroyl/myristoyl methyl glucamide (GlucoTain® Flex, ex Clariant Ltd.), cocoyl methyl glucamide (GlucoTain® Care, ex Clariant Ltd.), and mixtures thereof.
  • Preferred polyhydroxy fatty acid amides of general formula (III) for use in the invention include lauroyl methyl glucamide, myristoyl methyl glucamide, cocoyl methyl glucamide and mixtures thereof.
  • the level of polyhydroxy fatty acid amide of general formula (III) will preferably range from 3 to 5% by weight based on the total weight of the composition.
  • the polyhydroxy fatty acid amide of general formula (III) is selected from lauroyl methyl glucamide, myristoyl methyl glucamide, cocoyi methyl glucamide and mixtures thereof, in an amount ranging from 3 to 5% by weight based on the total weight of the composition.
  • alkylamidoalkyl betaines do not provide satisfactory performance in the context of this invention. Accordingly, it is preferred that such materials are absent from the composition of the invention, or included in minor quantities only, such less than 0.1 %, and more preferably less than 0.01 % by weight based on the total weight of the composition.
  • alkylamidoalkyl betaine in the context of this invention denotes materials having the general formula (IV):
  • An example of such a material is cocoamidopropyl betaine, in which RC(O) in general formula (IV) is a cocoyi group (as is further described above).
  • the weight ratio of first anionic surfactant (preferably alkyl ether sulfate of general formula (I)) to acyl glutamate of general formula (II) generally ranges from 2.5:1 to 1 :1 , and preferably ranges from 1 .5:1 to 1 :1 .
  • the weight ratio of acyl glutamate of general formula (II) to polyhydroxy fatty acid amide of general formula (III) generally ranges from 2.5:1 to 1 :1 , and preferably ranges from 1.5:1 to 1 :1.
  • composition of the invention preferably comprises one or more dispersed benefit agents selected from hydrophobic emulsion droplets and particulate solids.
  • the term "benefit agent” in the context of this invention includes materials which can provide a benefit to the hair and/or the scalp and/or the skin (preferably the hair and/or the scalp) as well as those materials which are beneficially incorporated into personal cleansing compositions, such as aesthetic agents.
  • Hydrophobic emulsion droplets for inclusion in the composition of the invention typically have a mean droplet diameter (D3,2) of 4 micrometres or less.
  • the mean droplet diameter (D3,2) is 1 micrometre or less, more preferably 0.5 micrometre or less, and most preferably 0.25 micrometre or less.
  • a suitable method for measuring the mean droplet diameter (D3,2) is by laser light scattering using an instrument such as a Malvern Mastersizer.
  • Preferred hydrophobic emulsion droplets in this context include emulsion droplets of hair and/or skin conditioning ingredients such as silicones and hydrocarbon oils.
  • Suitable silicones for use in the invention include polydiorganosiloxanes, in particular polydimethylsiloxanes (dimethicones), polydimethyl siloxanes having hydroxyl end groups (dimethiconols), and amino-functional polydimethylsiloxanes (amodimethicones).
  • polydiorganosiloxanes in particular polydimethylsiloxanes (dimethicones), polydimethyl siloxanes having hydroxyl end groups (dimethiconols), and amino-functional polydimethylsiloxanes (amodimethicones).
  • Such silicones are preferably non-volatile (with vapour pressure of less than 1000 Pa at 25°C), and preferably have a molecular weight of greater than 100,000, more preferably greater than 250,000.
  • Such silicones preferably have a kinematic viscosity of greater than 50,000 cS (mm 2 .s "1 ) and more preferably a kinematic viscosity of greater than 500,000 cS (mm 2 .s "1 ). Silicone kinematic viscosities in the context of this invention are measured at 25°C and can be measured by means of a glass capillary viscometer as set out further in Dow Corning Corporate Test Method CTM004 July 20, 1970.
  • Suitable silicones for use in the invention are available as pre-formed silicone emulsions from suppliers such as Dow Corning and GE Silicones. The use of such pre-formed silicone emulsions is preferred for ease of processing and control of silicone particle size.
  • Such pre-formed silicone emulsions will typically additionally comprise a suitable emulsifier, and may be prepared by a chemical emulsification process such as emulsion polymerisation, or by mechanical emulsification using a high shear mixer.
  • Pre-formed silicone emulsions having a mean droplet diameter (D3,2) of less than 0.15 micrometers are generally termed microemulsions.
  • Suitable pre-formed silicone emulsions include emulsions DC2-1766, DC2- 1784, DC-1785, DC-1786, DC-1788, DC-1310, DC-7123 and microemulsions DC2-1865 and DC2-1870, all available from Dow Corning. These are all emulsions/microemulsions of dimethiconol. Also suitable are amodimethicone emulsions such as DC939 (from Dow Corning) and SME253 (from GE Silicones). Mixtures of any of the above described silicone emulsions may also be used.
  • Suitable hydrocarbon oils for use in the invention include saturated, non-polar straight or branched- chain aliphatic or alicyclic hydrocarbons having from about 10 to about 50 carbon atoms, and mixtures thereof.
  • Such hydrocarbon oils preferably have a kinematic viscosity of 1 to 35 cS (mm 2 .s "1 ) at 40°C and a specific gravity of 0.76 to 0.87 at 25°C.
  • a preferred hydrocarbon oil in the context of the present invention is light mineral oil.
  • Mineral oils are clear oily liquids obtained from petroleum oil, from which waxes have been removed, and the more volatile fractions removed by distillation. The fraction distilling between 250°C to 300°C is termed mineral oil, and it consists of a mixture of hydrocarbons, in which the number of carbon atoms per hydrocarbon molecule generally ranges from Cio to C 40 .
  • the mineral oil may be characterised in terms of its viscosity, where light mineral oil is less viscous than heavy mineral oil.
  • a suitable light mineral oil will generally have a kinematic viscosity of 3.9 to 5.0 cS (mm 2 .s "1 ) at 40°C and a specific gravity of 0.810 to 0.830 at 25°C.
  • Such materials are commercially available under the brand name Lytol®.
  • Suitable particulate solids for inclusion in the composition of the invention include solid antimicrobial actives (such as zinc pyridinethione, climbazole, sulphur, piroctone olamine, octopirox, selenium disulphide and ketoconazole), solid colorants (such as hair dyes and pigments), and flaky or platelet pearlescers or opacifiers (such as magnesium aluminium silicate, zinc oxide, titanium dioxide and coated mica).
  • solid antimicrobial actives such as zinc pyridinethione, climbazole, sulphur, piroctone olamine, octopirox, selenium disulphide and ketoconazole
  • solid colorants such as hair dyes and pigments
  • flaky or platelet pearlescers or opacifiers such as magnesium aluminium silicate, zinc oxide, titanium dioxide and coated mica.
  • the level of dispersed benefit agent depends on the particular material(s) used, but generally ranges from 0.01 to 20%, preferably from 0.02 to 10% by weight based on the total weight of the composition.
  • the one or more dispersed benefit agents includes one or more silicone emulsions (as further described above) and the level of silicone (per se as active ingredient) ranges from 0.01 to 10%, preferably from 0.5 to 5% by weight based on the total weight of the composition.
  • composition of the invention preferably includes one or more cationic polymers.
  • Such polymers may enhance the delivery of conditioning agents and thereby improve the conditioning benefits obtained.
  • Cationic polymers typically contain cationic nitrogen-containing groups such as quaternary ammonium or protonated amino groups.
  • the protonated amino groups can be primary, secondary, or tertiary amines (preferably secondary or tertiary).
  • the cationic nitrogen-containing group of the cationic polymer is generally present as a substituent on all, or more typically on some, of the repeat units making up the polymer.
  • the cationic nitrogen-containing groups are selected from quaternary ammonium groups bearing three radicals, which may be identical or different, chosen from hydrogen and alkyl radicals containing 1 to 10, more preferably 1 to 6 and most preferably 1 to 3 carbon atoms.
  • Any anionic counterion can be used in association with the cationic polymer so long as the counterion is physically and chemically compatible with the essential components of the composition or does not otherwise unduly impair product performance, stability or aesthetics.
  • counterions include halides (e.g., chloride, fluoride, bromide, iodide), sulfate and methylsulfate.
  • the weight average molecular weight (Mw) of the cationic polymer is preferably from about 5,000 to about 10 million, more preferably from about 100,000 to about 1 million g/mol.
  • the cationic polymer generally has a cationic charge density ranging from about 0.2 to about 7 meq/gm.
  • cationic charge density in the context of this invention refers to the ratio of the number of positive charges on a monomeric unit of which a polymer is comprised to the molecular weight of the monomeric unit. The charge density multiplied by the polymer molecular weight determines the number of positively charged sites on a given polymer chain. Cationic charge density can be determined according to the Kjeldahl Method. Those skilled in the art will recognize that the charge density of amino-containing polymers may vary depending upon pH and the isoelectric point of the amino groups. The charge density should be within the above limits at the pH of intended use. Cationic polymers for use in the invention preferably have a cationic charge density ranging from about 0.3 to about 4 meq/g, more preferably from about 0.4 to about 3.5 meq/g.
  • Suitable cationic polymers for use in the invention include cationic polysaccharide derivatives, such as cationic cellulose derivatives, cationic starch derivatives, and cationic guar gum derivatives.
  • Preferred cationic polysaccharide derivatives for use in the invention include cationic guar gum derivatives and cationic cellulose derivatives.
  • Examples of preferred cationic guar gum derivatives for use in the invention include guar hydroxypropyltrimethylammonium chlorides such as JAGUAR ® C13S, JAGUAR ® C14, JAGUAR® C15 and JAGUAR ® C17.
  • Examples of preferred cationic cellulose derivatives for use in the invention include poly(1 ,2-oxyethanediyl)-2-hydroxy-3-trimethylammonium propyl chloride cellulose ethers (INCI: Polyquaternium-10) such as UCARE® Polymer JR-125, UCARE® Polymer JR- 400, UCARE® Polymer JR-30M, UCARE® Polymer LR-400 and UCARE® Polymer LR- 30M.
  • poly(1 ,2-oxyethanediyl)-2-hydroxy-3-trimethylammonium propyl chloride cellulose ethers such as UCARE® Polymer JR-125, UCARE® Polymer JR- 400, UCARE® Polymer JR-30M, UCARE® Polymer LR-400 and UCARE® Polymer LR- 30M.
  • the total level of cationic polymer in the composition is preferably from 0.01 to 2% and more preferably from 0.05 to 1 % by weight based on the total weight of the composition.
  • the composition of the invention preferably includes one or more structurants to assist in the suspension of dispersed benefit agent and provide phase stability. Suitable structurants include polyacrylic acids, cross-linked polymers of acrylic acid, copolymers of acrylic acid with a hydrophobic monomer, copolymers of carboxylic acid-containing monomers and acrylic esters, cross-linked copolymers of acrylic acid and acrylate esters, heteropolysaccharide gums and crystalline long chain acyl derivatives.
  • the total level of structurant is generally 0.05 to 5%, preferably from 0.1 to 4%, more preferably from 0.2 to 2% by weight based on the total weight of the
  • the composition of the invention may suitably include at least one inorganic electrolyte.
  • the inorganic electrolyte may be used to help provide viscosity to the composition.
  • the viscosity of the composition suitably ranges from 6,000 to 10,000 mPa.s, preferably from 7,000 to 9,000 mPa.s, more preferably from 7,500 to 8,500 mPa.s when measured using a Brookfield V2 viscometer (spindle RTV5, 1 minute, 20rpm) at 30°C.
  • Suitable inorganic electrolytes include metal chlorides (such as sodium chloride, potassium chloride, calcium chloride, magnesium chloride, zinc chloride, ferric chloride and aluminium chloride) and metal sulfates (such as sodium sulfate and magnesium sulfate).
  • metal chlorides such as sodium chloride, potassium chloride, calcium chloride, magnesium chloride, zinc chloride, ferric chloride and aluminium chloride
  • metal sulfates such as sodium sulfate and magnesium sulfate
  • Examples of preferred inorganic electrolytes for use in the invention include sodium chloride, potassium chloride, magnesium sulfate and mixtures thereof.
  • the level of inorganic electrolyte in compositions of the invention generally ranges from about 1 to about 25%, preferably from about 2 to about 20%, more preferably from about 3 to about 15% (by total weight inorganic electrolyte based on the total weight of the composition).
  • a composition of the invention may contain further optional ingredients to enhance performance and/or consumer acceptability.
  • ingredients include fragrance, dyes and pigments, pH adjusting agents and preservatives or antimicrobials.
  • Each of these ingredients will be present in an amount effective to accomplish its purpose.
  • these optional ingredients are included individually at a level of up to 5% by weight based on the total weight of the composition.
  • a mildly acidic pH is often desirable in shampoos for reasons such as reduced hair fibre swelling, improved hair lustre, better compatibility with acidic skin or hair care actives in the formulation and optimized efficacy of certain organic preservative systems.
  • the pH of the composition of the invention preferably ranges from 3 to 6, more preferably from 4 to 5.5 and most preferably from 4.5 to 5.1 .
  • composition of the invention is primarily intended for topical application to the body, preferably the hair and scalp.
  • composition of the invention is topically applied to the hair and then massaged into the hair and scalp.
  • the composition is then rinsed off the hair and scalp with water prior to drying the hair.
  • Examples 1 and 2 represent formulations according to the invention. Examples A and B represent comparative examples (not according to the invention). Table 1
  • the formulations were stored in a 5°C fridge and their transparency monitored over time. Each formulation was also evaluated for extensional viscosity using an extensional rheometer (HAAKETM CaBERTM 1 Capillary Breakup Extensional Rheometer). After placing a sample between two plates, the upper plate moves upwards at very high speed and produces a fluid filament. A laser micrometer is used to determine the decrease in filament diameter as a function of time.
  • extensional rheometer HAAKETM CaBERTM 1 Capillary Breakup Extensional Rheometer
  • phase behaviour of each formulation was also determined by microscopy studies on bulk and dried samples.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

La présente invention concerne une composition d'hygiène personne comprenant, dans une phase continue aqueuse : (i) de 3 à 10% (en poids sur la base du poids total de la composition) d'un premier tensioactif anionique qui est, de préférence, choisi parmi des sulfates d'lkyléther de formule générale (I) : R-O-(CH2CH2-O)n-SO3 -M+, dans laquelle R est un groupe alkyle à chaîne droite ou ramifiée possédant 10 à 14 atomes de carbone, n est un nombre, allant de 2 à 5, qui représente le degré d'éthoxylation, et M est un cation solubilisant choisi parmi un métal alcalin, ammonium, ammonium substitué ou des cations d'amine organique ; (ii) de 2 à 8% (en poids sur la base du poids total de la composition) d'un second tensioactif anionique qui est différent du premier tensioactif anionique et qui est choisi parmi des glutamates d'acyle de formule générale (II) dans laquelle COR1 est un groupe acyle linéaire ou ramifié possédant 6 à 22 atomes de carbone et 0, 1, 2 ou 3 liaison(s) double(s), et chaque X représente indépendamment hydrogène ou un cation solubilisant choisi parmi un métal alcalin, ammonium, ammonium substitué ou des cations d'amine organique ; et (iii) de 1 à 6% (en poids sur la base du poids total de la composition) d'un tensioactif non ionique choisi parmi des poly(hydroxy)amides d'acide gras de formule générale (III) dans laquelle R2CO représente un groupe acyle linéaire ou ramifié possédant 6 à 22 atomes de carbone et 0, 1, 2 ou 3 liaison(s) double(s), et R1 est choisi parmi des groupes alkyle C1-4 et des groupes alkyle C1-4 à substitution hydroxy.
PCT/EP2017/064419 2016-06-17 2017-06-13 Composition d'hygiène personnelle Ceased WO2017216162A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16175121.9 2016-06-17
EP16175121 2016-06-17

Publications (1)

Publication Number Publication Date
WO2017216162A1 true WO2017216162A1 (fr) 2017-12-21

Family

ID=56137206

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/064419 Ceased WO2017216162A1 (fr) 2016-06-17 2017-06-13 Composition d'hygiène personnelle

Country Status (2)

Country Link
AR (1) AR108796A1 (fr)
WO (1) WO2017216162A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096878B2 (en) 2018-05-31 2021-08-24 L'oreal Concentrated rinse-off cleansing composition
WO2021245159A1 (fr) * 2020-06-04 2021-12-09 Unilever Ip Holdings B.V. Système tensioactif d'origine naturelle et composition le comprenant
CN114727919A (zh) * 2019-11-19 2022-07-08 联合利华知识产权控股有限公司 毛发护理组合物
US12419821B2 (en) 2018-05-31 2025-09-23 L'oreal Anti-dandruff cleansing composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009814A (en) * 1987-04-08 1991-04-23 Huls Aktiengesellschaft Use of n-polyhydroxyalkyl fatty acid amides as thickening agents for liquid aqueous surfactant systems
US20140215727A1 (en) * 2011-06-10 2014-08-07 Kristin Olsson Cleansing composition
US20160143828A1 (en) * 2013-06-28 2016-05-26 Clariant International Ltd. Use Of Special N-Alkyl-N-Acylglucamines For Conditioning Hair In Hair Washing Agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009814A (en) * 1987-04-08 1991-04-23 Huls Aktiengesellschaft Use of n-polyhydroxyalkyl fatty acid amides as thickening agents for liquid aqueous surfactant systems
US20140215727A1 (en) * 2011-06-10 2014-08-07 Kristin Olsson Cleansing composition
US20160143828A1 (en) * 2013-06-28 2016-05-26 Clariant International Ltd. Use Of Special N-Alkyl-N-Acylglucamines For Conditioning Hair In Hair Washing Agents

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096878B2 (en) 2018-05-31 2021-08-24 L'oreal Concentrated rinse-off cleansing composition
US12419821B2 (en) 2018-05-31 2025-09-23 L'oreal Anti-dandruff cleansing composition
CN114727919A (zh) * 2019-11-19 2022-07-08 联合利华知识产权控股有限公司 毛发护理组合物
CN114727919B (zh) * 2019-11-19 2024-07-23 联合利华知识产权控股有限公司 毛发护理组合物
WO2021245159A1 (fr) * 2020-06-04 2021-12-09 Unilever Ip Holdings B.V. Système tensioactif d'origine naturelle et composition le comprenant

Also Published As

Publication number Publication date
AR108796A1 (es) 2018-09-26

Similar Documents

Publication Publication Date Title
US8530399B2 (en) Conditioning shampoo compositions
US20180256470A1 (en) Personal cleansing composition
JP7539839B2 (ja) 硫酸塩不含クレンジング組成物
EP1817080A1 (fr) Formules de shampoing contenant un mélange de polymère cationique et de tensioactif anionique
CN115776878A (zh) 毛发护理组合物
US12059485B2 (en) Personal cleansing compositions comprising a surfactant system consisting of an alkyl ether sulfate and betaine
WO2017216162A1 (fr) Composition d'hygiène personnelle
WO2010052071A2 (fr) Composition
JP7126945B2 (ja) パーソナルケア組成物及び該組成物の使用方法
WO2017063806A1 (fr) Composition d'hygiène personnelle
EP3463261B1 (fr) Compositions antimicrobiennes d'hygiène corporelle
EP3294258B1 (fr) Composition d'hygiène personnelle liquide
WO2025124894A1 (fr) Compositions nettoyantes
WO2025124892A1 (fr) Compositions nettoyantes à sulfate de décyl-éther de sodium
WO2025124888A1 (fr) Système tensioactif d'alkyl éther sulfates pour le nettoyage
WO2025119712A1 (fr) Compositions nettoyantes
BR112020022902B1 (pt) Composição de higiene e método de tratamento dos cabelos
BR112020022887B1 (pt) Composição de higiene e método de tratamento dos cabelos
WO2016131627A1 (fr) Composition pour l'hygiène personnelle
BR112020022887A2 (pt) composição de higiene e método de tratamento dos cabelos

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17729142

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17729142

Country of ref document: EP

Kind code of ref document: A1